SciTransfer
Organization

Union Biometrica BVBA

Belgian life-science instrument company providing biological analysis technology and industry mentorship to European PhD training consortia.

Scientific instrument companyhealthBENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
Unique partners
27
What they do

Their core work

Union Biometrica BVBA is a Belgian private company that provides specialized scientific instrumentation and industry expertise to academic life-science research communities. Their participation in H2020 comes exclusively as a third party — meaning they contribute equipment, training environments, or commercial know-how to consortia rather than receiving direct EC funding or leading research directions. Both projects they appear in are MSCA Innovative Training Networks focused on bioimaging and developmental cell biology, which points to instruments or services used for biological object analysis, sorting, or imaging. For a business audience: they are a technology supplier to the academic biology world, with established ties to pan-European PhD training ecosystems.

Core expertise

What they specialise in

Bioimaging instrumentation and technologyprimary
2 projects

Both ImageInLife and PolarNet are bioimaging-centered training networks, and Union Biometrica joined both as a third-party contributor, suggesting recurring value as an imaging technology provider.

Developmental biology research toolsprimary
1 project

ImageInLife (2017–2021) focused on multilevel bioimaging and modelling of vertebrate development, a domain where specialized biological sorting and imaging instruments are essential.

Cell polarity and quantitative cell biologysecondary
1 project

PolarNet (2015–2019) integrated genetic, biophysical and computational approaches to study polarity — a context where precise biological object analysis technology is a core enabling tool.

Industry-academia technology transfer via training networkssecondary
2 projects

Appearing as a third party in two large MSCA-ITN-ETN consortia indicates a deliberate strategy of embedding commercial technology within PhD-level European training programs.

Evolution & trajectory

How they've shifted over time

Early focus
Cell polarity and biophysical analysis
Recent focus
Multilevel vertebrate bioimaging

With only two projects and no keyword data, a detailed evolution analysis is not possible. Both projects overlap in time (2015–2019 and 2017–2021) and span the same general domain — quantitative bioimaging of cellular and developmental processes — so no clear thematic shift is visible from the CORDIS data alone. What can be noted is that the later project (ImageInLife) has a broader, more applied scope (multilevel imaging of vertebrate development) compared to the more mechanistic focus of PolarNet (principles of cellular polarity), which may hint at a gradual move toward application-side imaging platforms.

Their trajectory points toward broader biological imaging applications — from single-cell polarity questions toward whole-organism developmental imaging — which aligns with growing demand for high-throughput analysis of model organisms like zebrafish embryos.

Collaboration profile

How they like to work

Role: third_party_expertReach: European7 countries collaborated

Union Biometrica has never coordinated an H2020 project and always appears as a third party — the structural position of an industrial contributor providing access to specialized equipment, internship opportunities, or commercial expertise rather than conducting primary research. Their 27 unique partners across just 2 projects reflects involvement in large, multi-institutional consortia that are typical of MSCA training networks. This means working with them is less about co-authoring research and more about accessing their instruments or industrial environment for training or validation purposes.

27 unique consortium partners across 7 countries from only 2 projects reflects the scale typical of MSCA-ITN-ETN consortia, which routinely involve 10–15 academic nodes plus industry partners. Their network is European in scope but mediated entirely through large academic training consortia rather than direct bilateral partnerships.

Why partner with them

What sets them apart

As a non-SME Belgian private company appearing exclusively as a third party in MSCA training networks, Union Biometrica fills a specific and recurring role: the industry participant that gives PhD students access to commercial-grade instrumentation and real-world research workflows. Consortium builders assembling MSCA networks who need a credible industrial life-science technology partner with prior ETN experience should consider them. Their positioning is narrow but well-matched to European training network requirements where industry co-mentorship of doctoral researchers is a formal requirement.

Notable projects

Highlights from their portfolio

  • ImageInLife
    A large MSCA training network on multilevel bioimaging of vertebrate development — one of the most technically demanding bioimaging domains — making it the more application-rich of Union Biometrica's two engagements.
  • PolarNet
    An interdisciplinary network combining genetics, biophysics and computation to study cell polarity, demonstrating Union Biometrica's reach into fundamental quantitative cell biology alongside applied imaging.
Cross-sector capabilities
pharmaceutical high-throughput screeningagricultural model organism researchfood safety biological testingenvironmental toxicology assays
Analysis note: Third-party status in both projects means no EC funding was received directly and no keyword metadata is available from CORDIS. The profile is substantially inferred from project titles and the structural logic of MSCA-ITN-ETN consortia. Only 2 projects across a narrow 2-year window of entry (2015–2017) makes expertise evolution analysis unreliable. The org_type and what_they_do are informed by domain knowledge about the life-science instrumentation sector consistent with this project portfolio, but should be verified against the company's own website.